Mats A. Bergman (), David Granlund () and Niklas Rudholm ()
Additional contact information
Mats A. Bergman: Department of Economics, Södertörn University, Postal: Department of Economics, Södertörn University, 141 89 Huddinge, Sweden
David Granlund: Department of Economics, Umeå University, Postal: Department of Economics, Umeå University, S 901 87 Umeå, Sweden
Niklas Rudholm: Department of Economics, Postal: Dalarna University, SE-781 88 Borlänge, Sweden
Abstract: We study the effect of the degree of exclusivity for the lowest bidder on the average price of generic pharmaceuticals in the short and long terms. Our results indicate that a 1-percentage-point gain in market share of the lowest bidder reduces average costs by 0.3% in the short term and 0.8% in the long term, but also reduces the number of firms by 1%. We find that reducing the number of firms has a strong positive (and hence counteracting) effect on average prices, i.e., a 1% reduction raises prices by approximately 1%.
Keywords: Pharmaceutical industry; generic competition; generic drugs; brand-name drugs
38 pages, February 2, 2016
Full text files
175781_ues921.pdf
Questions (including download problems) about the papers in this series should be directed to David Skog ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2024-02-05 17:13:52.